Global Access Program

Universal access to quality healthcare and medical innovation remains a global challenge.
To address this challenge, many of the world's top relief and aid organizations have joined together with an ambitious goal: to end stop many diseases.
In 2014, Roche announced, the Global Access Program. In 2019, the Program was expanded to include Tuberculosis (TB), Hepatitis B and C (HBV and HCV), and Human Papillomavirus (HPV).
Roche continues to partner with national governments, local healthcare facilities, communities and international agencies, including UNAIDS, CHAI, Unitaid, the U.S. President's Emergency Plan for AIDS Relief (PEPFAR), Global Fund, and Centres for Disease Control (CDC), to establish The Global Access Program that would go beyond providing diagnostic tests.
Since its inception, the program has expanded substantially in menu and geographic footprint to provide increased access to diagnostics at affordable pricing for qualifying organizations in eligible countries with the highest disease burden.  

  1. UNAIDS Core Epidemiology Slides, July 2015. sites/default/files/media_asset/20150714_epi_core_en.pdf. Accessed June 13, 2016.
  2. UNAIDS Report on the global AIDS epidemic. 2010. Accessed June 13, 2016.
  3. 90-90-90 An ambitious treatment target to help end the AIDS epidemic. 2014. unaids/contentassets/documents/unaidspublication/ 2014/90-90-90_en.pdf. Accessed June 13, 2016.
  4. Pavia AT. Primary care of infants and children with HIV. http:// Accessed June 13, 2016.
  5. UNAIDS 2013 | AIDS by the numbers. default/files/media_asset/ JC2571_AIDS_by_the_numbers_en_1.pdf. Accessed June 13, 2016.